News
DSKYF
18.35
NaN%
--
Weekly Report: what happened at DSKYF last week (0413-0417)?
Weekly Report · 2d ago
Daiichi Sankyo Advances ADC Pipeline With New Esophageal Cancer Study
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Daiichi Sankyo Company (OtherDSKYF) and Arcutis Biotherapeutics (ARQT)
TipRanks · 04/15 10:10
Suntory buying Daiichi Sankyo unit for $1.3B, Nikkei reports
Seeking Alpha · 04/15 05:10
Weekly Report: what happened at DSKYF last week (0406-0410)?
Weekly Report · 04/13 09:09
Weekly Report: what happened at DSKYF last week (0330-0403)?
Weekly Report · 04/06 09:09
Nuvation Bio gains global rights to brain cancer therapy from Daiichi Sankyo
Seeking Alpha · 04/01 13:01
Nuvation Bio Acquires Japan Rights For Safusidenib; Now Owns Global Clinical Development Program
NASDAQ · 04/01 12:14
Weekly Report: what happened at DSKYF last week (0323-0327)?
Weekly Report · 03/30 09:09
Analysts Offer Insights on Healthcare Companies: Beam Therapeutics (BEAM), Maze Therapeutics, Inc. (MAZE) and Daiichi Sankyo Company (OtherDSKYF)
TipRanks · 03/26 10:20
Weekly Report: what happened at DSKYF last week (0316-0320)?
Weekly Report · 03/23 09:08
Daiichi Sankyo Terminates Early Cancer Trial DS-9606a: What Investors Should Know
TipRanks · 03/20 16:30
Daiichi Sankyo Backs Triple Cholesterol Therapy in New Phase 3 Heart Study
TipRanks · 03/19 16:31
Weekly Report: what happened at DSKYF last week (0309-0313)?
Weekly Report · 03/16 09:08
Daiichi Sankyo Company (DSKYF) Receives a Buy from Nomura
TipRanks · 03/12 10:18
Weekly Report: what happened at DSKYF last week (0302-0306)?
Weekly Report · 03/09 09:08
Daiichi Sankyo: FDA Grants Priority Review For ENHERTU
NASDAQ · 03/09 07:01
Weekly Report: what happened at DSKYF last week (0223-0227)?
Weekly Report · 03/02 09:08
Daiichi Sankyo Advances Triple Cholesterol Combo Pill With Completed Bioequivalence Study
TipRanks · 02/27 16:35
UBS Sticks to Their Hold Rating for Daiichi Sankyo Company (DSKYF)
TipRanks · 02/27 10:16
More
Webull provides a variety of real-time DSKYF stock news. You can receive the latest news about Daiichi Sankyo through multiple platforms. This information may help you make smarter investment decisions.
About DSKYF
Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.